Current etf page

Catalysts

XLV Stock Catalysts

Earnings · Growth Drivers · Events · AIQ Catalyst

Financial ServicesAsset ManagementScore data as of Sep 4, 2026

XLV

Catalysts
State Street Health Care Select Sector SPDR ETF
Financial Services· Asset Management
AIQ Score
NeutralAIQ Edge 9/10
Relative Leader / Watch
Strong Relative Position
Score data as of Sep 4, 2026
Last price
$171.45
-$1.81 (-1.04%)
Latest market quote
Momentum68
Value49
Quality71
Risk Resilience61
Sentiment
View financial data

Stock Catalyst Board

Earnings timing, analyst expectations, news pressure, growth drivers, events, and AIQ Catalyst context.

Next earnings

No upcoming reporting date is available yet.

AIQ Catalyst
AIQ 62/100

Momentum 68/100 and sentiment before the next covered event.

Recent coverage
4 articles

Updated Sep 5, 2026 · Sentiment 48.47%

Earnings History And Surprises

See whether reported EPS and revenue have consistently exceeded or missed analyst expectations.

Earnings Expectations And Results

Compare what analysts expected with what the company reported across recent quarters.

Momentum 68/100AIQ Edge 9/10 Strong Relative Position
Beat rate
No comparable periods
Average surprise
Across covered historical reports
Latest result
No reported result
EPS estimate versus actual
Actual bars are colored by beat, inline result, or miss.
No plotted estimate/actual history in this snapshot.
Earnings history

No earnings history rows in this snapshot.

Analyst Forecast And Price Targets

Wall Street consensus, rating distribution, and the current 12-month target range.

Analyst ratings
-
covered analysts
No rating distribution in this snapshot.
12-month analyst target
versus current price
Based on available analyst observations. Targets are estimates, not predictions.
No analyst target path in this snapshot.
Low target
Average target
High target

Event Read

Catalysts should explain what can change the setup, when it might happen, and which AIQ component would move first.

Current event setup

Event date

Upcoming earnings date not available yet.

EPS estimate$0.40

Current analyst expectation for the upcoming report.

Sentiment score

News pressure around the setup.

Momentum score68

Where event reaction would show up first.

AIQ score62/100

Composite decision read before event confirmation.

Analyst context

Analyst targets and estimate revisions are not included in the current coverage.

News And Sentiment

Recent company coverage, scored where source sentiment is available.

Positive
3
Neutral
1
Negative
0
etftrends.com · Aug 10, 2026

Sector ETFs Post Record $25B Inflow as Tech Leads

Sector ETFs set a record $25 billion inflow in July, as investors bought tech's dip, backed financials' earnings and leaned into health care.

finance.yahoo.com · Jul 9, 2026

Two Drugmakers Own 90% of the Obesity Boom. One Fund Owns Both for 0.59%

The Health Care Select Sector SPDR Fund (NYSEARCA:XLV) is the default healthcare allocation for millions of investors, and for good reason. XLV owns the entire S&P 500 healthcare complex in one ticker: insurers, device makers, biotech, and Big Pharma. It has returned 21.61% over the past year and 159.84% over ten years. If the reason ... Two Drugmakers Own 90% of the Obesity Boom. One Fund Owns Both for 0.59%

finance.yahoo.com · Jun 13, 2026

3 Ridiculously Cheap Healthcare Stocks to Buy in June

Healthcare has spent 2026 on the sidelines while the rest of the market does the heavy lifting. The Health Care Select Sector SPDR Fund (NYSEARCA:XLV) is down around 1% year to date even after a 6% one-month bounce. That stagnation has left a handful of high-margin operators trading at forward multiples that look out of ... 3 Ridiculously Cheap Healthcare Stocks to Buy in June

etftrends.com · Jun 11, 2026

Healthcare ETFs: From Broad Exposure to Big Breakthroughs

Healthcare ETFs span broad sector exposure, pharmaceuticals, biotechnology, and weight-loss drugs to provide opportunities beyond tech.

Open full news and sentiment

XLV Catalysts FAQ

What are the next catalysts for XLV stock?

XLV's next stock catalysts can include earnings, guidance, analyst ratings, price-target changes, estimate revisions, product updates, regulatory events, contracts, or sector developments. Use this page to connect those events with AIQ and market context.

What upcoming events could move XLV stock?

Upcoming events that could move XLV include earnings reports, management commentary, estimate changes, major news, and market-wide sector catalysts.

How could XLV's next earnings report affect the stock?

XLV's next earnings report could affect the stock by changing revenue expectations, EPS estimates, guidance, analyst ratings, price targets, estimate revisions, and momentum.

What could drive XLV stock higher?

XLV could move higher if earnings, guidance, demand trends, analyst expectations, or AIQ momentum improve relative to what the market already expects.

What events could hurt XLV stock?

XLV could be hurt by weaker guidance, negative estimate revisions, margin pressure, adverse news, regulatory issues, or a sector-wide risk-off move.